News GLP-1 receptor agonists: European drug regulator asks makers for evidence of self-harm BMJ 2023; 383 doi: https://doi.org/10.1136/bmj.p2906 (Published 08 December 2023) Cite this as: BMJ 2023;383:p2906 Article Related content Metrics Responses Peer review Related articles No related articles found. See more Patient related outcome measures (PROMs) in long term conditions—is it time to bring them into routine clinical practice? BMJ September 06, 2024, 386 q1921; DOI: https://doi.org/10.1136/bmj.q1921 SGLT-2 inhibitors for diabetes may help prevent dementia, study finds BMJ August 28, 2024, 386 q1875; DOI: https://doi.org/10.1136/bmj.q1875 Helen Salisbury: GP collective action to end unfunded work BMJ August 13, 2024, 386 q1780; DOI: https://doi.org/10.1136/bmj.q1780 Diabetes: One in 10 patients on NHS’s “soups and shakes” diet plan went into remission BMJ August 06, 2024, 386 q1733; DOI: https://doi.org/10.1136/bmj.q1733 Helen Salisbury: Failings at the Care Quality Commission BMJ August 02, 2024, 386 q1713; DOI: https://doi.org/10.1136/bmj.q1713
